MEI Chosen To Participate In FDA Approved Clinical Trial
Milauskas Eye Institute is proud to have been selected to participate in a Phase 3 FDA approved Clinical Trial involving cataract surgery and sustained release medication delivered at the time of surgery.
We are very excited to be part of this trial and the growing world of medical research for improved patient results. Milauskas Eye Institute takes great pride in providing you with the best eye care possible and being involved in shaping the future of improved medicine. Ask your eye doctor if you are a candidate for this exciting new clinical trial.
